123 related articles for article (PubMed ID: 24606462)
1. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
[TBL] [Abstract][Full Text] [Related]
2. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
3. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
[TBL] [Abstract][Full Text] [Related]
4. Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.
Xia P; An HX; Dang CX; Radpour R; Kohler C; Fokas E; Engenhart-Cabillic R; Holzgreve W; Zhong XY
BMC Cancer; 2009 Dec; 9():454. PubMed ID: 20025731
[TBL] [Abstract][Full Text] [Related]
5. Cell-free circulating mitochondrial DNA in the serum: a potential non-invasive biomarker for Ewing's sarcoma.
Yu M; Wan YF; Zou QH
Arch Med Res; 2012 Jul; 43(5):389-94. PubMed ID: 22728238
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients.
Sundquist K; Sundquist J; Hedelius A; Memon AA
Mol Carcinog; 2020 Dec; 59(12):1362-1370. PubMed ID: 33051887
[TBL] [Abstract][Full Text] [Related]
7. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients.
Yu M; Zhou Y; Shi Y; Ning L; Yang Y; Wei X; Zhang N; Hao X; Niu R
IUBMB Life; 2007 Jul; 59(7):450-7. PubMed ID: 17654121
[TBL] [Abstract][Full Text] [Related]
8. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population.
Jiang H; Zhao H; Xu H; Hu L; Wang W; Wei Y; Wang Y; Peng X; Zhou F
Cancer Sci; 2014 Jun; 105(6):639-45. PubMed ID: 24703408
[TBL] [Abstract][Full Text] [Related]
10. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection.
Maragh S; Veltri RW; Lund SP; Mangold L; Isharwal S; Christudass CS; Partin AW; Humphreys EB; Sorbara L; Srivastava S; Wagner PD
Cancer Biomark; 2015; 15(6):763-73. PubMed ID: 26406418
[TBL] [Abstract][Full Text] [Related]
13. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
14. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
15. Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich's ataxia.
Dantham S; Srivastava AK; Gulati S; Rajeswari MR
J Neurol Sci; 2016 Jun; 365():82-8. PubMed ID: 27206881
[TBL] [Abstract][Full Text] [Related]
16. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
17. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
18. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.
Weerts MJA; Timmermans EC; van de Stolpe A; Vossen RHAM; Anvar SY; Foekens JA; Sleijfer S; Martens JWM
Neoplasia; 2018 Jul; 20(7):687-696. PubMed ID: 29842994
[TBL] [Abstract][Full Text] [Related]
20. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
